ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Overview Fund Activity
Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

38 hedge funds and large institutions have $57M invested in Adamas Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
$23.8M
2
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
$10M
3
WSA
Wall Street Associates
California
$4.11M
4
EA
Emerald Advisers
Pennsylvania
$2.77M
5
BA
BlackRock Advisors
Delaware
$1.95M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
TCIM
26
TIAA CREF Investment Management
New York
$152K +$152K +8,335 New
BIM
27
BlackRock Investment Management
Delaware
$142K +$142K +7,781 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$97K +$97K +5,300 New
TA
29
Teachers Advisors
New York
$76K +$76K +4,134 New
TRCT
30
Tower Research Capital (TRC)
New York
$54K +$54K +2,969 New
NFA
31
Nationwide Fund Advisors
Ohio
$38K +$38K +2,064 New
AIG
32
American International Group
New York
$34.9K +$34.9K +1,911 New
AllianceBernstein
33
AllianceBernstein
Tennessee
$15K +$15K +800 New
U
34
UBS
Switzerland
$12K +$12K +634 New
VFA
35
Virtus Fund Advisers
Connecticut
$5K +$5K +249 New
Wells Fargo
36
Wells Fargo
California
$4K +$4K +208 New
Barclays
37
Barclays
United Kingdom
$1K +$1K +64 New
Citigroup
38
Citigroup
New York
$1K +$1K +64 New
1
2